滚动资讯
Thermo FisherTMO Thermo Fisher Scientific Inc falls 2.95 percent post Q4 2025 earnings despite narrow EPS beat and 3.9 percent year-over-year revenue growth. - Investment Community Signals - UBND thành phố Hải PhòngFierceBiotech礼来公司放弃与瑞格生物剩余协议，RIPK1抑制剂再遭打击。Thermo FisherThermo Fisher (TMO) Q4 2024 Earnings Transcript - AOL.comWatersWAT (Waters Corporation) rises 1.06 percent after Q4 2025 results, as 7 percent revenue growth offsets minor EPS miss. - Earnings Risk - Cổng thông tin điện tử Tỉnh Sơn LaFierceBiotech麦克森以12.5亿美元将外科部门少数股权置换给阿波罗基金。FierceBiotechAcuityMD raises $80M to help bolster AI in the medtech industryFierceBiotechAACR: NCI leader Letai battles ‘misinformation’ to assure anxious researchers that ‘funding is strong’FierceBiotechMerck goes with Google for AI push, striking enterprise partnership worth up to $1BBioWorldAppointments and advancements for April 22, 2026BioWorldFinancings for April 22, 2026BioWorldIn the clinic for April 22, 2026BioWorldOther news to note for April 22, 2026
Thermo Fisher 2025年12月25日

赛默飞世尔科技公司（TMO）股票展望：最新动态、分析师预测与2026年关键催化剂（2025年12月25日）- ts2.tech

赛默飞世尔科技公司（TMO）股票展望：最新动态、分析师预测与2026年关键催化剂（2025年12月25日）- ts2.tech

原文
暂时没有全文，请查看原始来源。